STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy

NARecruitingINTERVENTIONAL
Enrollment

880

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
Immune Checkpoint Therapy
Interventions
DIAGNOSTIC_TEST

Troponin surveillance

Troponin will be monitored prior to each immune checkpoint inhibitor infusion for the first 12 weeks of therapy.

OTHER

Standard of care

Standard of care if symptoms arise then evaluation with cardiac biomarkers and/or further cardiac testing.

Trial Locations (1)

77030

RECRUITING

MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER